fenofibrate has been researched along with psi-baptigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
| Doddareddy, MR; Gavande, N; Groundwater, PW; Hibbs, DE; Matin, A; Nammi, S; Roubin, RH | 1 |
| Balaban, S; Cairns, R; Gao, Q; Grewal, T; Groundwater, PW; Hanh, J; Hibbs, DE; Hoy, AJ; Lai, F; Liao, VW; Lin, HY; Ong, JA; Sjöström, H; Váradi, L; Wood, P | 1 |
3 other study(ies) available for fenofibrate and psi-baptigenin
| Article | Year |
|---|---|
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HEK293 Cells; Humans; Isoflavones; Models, Molecular; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Structure-Activity Relationship | 2013 |
Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
Topics: 3T3-L1 Cells; Animals; Cell Line; Diabetes Mellitus, Type 2; Drug Design; HEK293 Cells; Humans; Ligands; Lipid Metabolism; Mice; Molecular Docking Simulation; PPAR alpha; PPAR gamma; Small Molecule Libraries | 2015 |